Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Generation of specific cytotoxic T cells with a fragment of the Epstein-Barr virus-encoded p63/latent membrane protein.

Literature DB >> 3037547

Generation of specific cytotoxic T cells with a fragment of the Epstein-Barr virus-encoded p63/latent membrane protein.

Abstract

Human B lymphocytes, transformed by the herpesvirus Epstein-Barr virus, are known to express a characteristic antigen(s) recognized by the cellular immune response. This structure has been termed lymphocyte-determined membrane antigen. Because of the significance of this structure in controlling Epstein-Barr virus infection in vivo, the molecular nature of lymphocyte-determined membrane antigen has been long sought. In this paper, we show that a sequence of 10 amino acids (residues 43-53) from the Epstein-Barr virus-encoded membrane protein p63/latent membrane protein can induce Epstein-Barr virus-specific cytotoxic T cells and, therefore, bears at least one of the lymphocyte-determined membrane antigenic determinants.

Entities: Disease Species

Mesh：

Substances：

Year: 1987 PMID： 3037547 PMCID： PMC298860 DOI： 10.1073/pnas.84.15.5384

Source DB: PubMed Journal: Proc Natl Acad Sci U S A ISSN： 0027-8424 Impact factor: 11.205

27 in total

1. Long-term T-cell-mediated immunity to Epstein-Barr virus in man. I. Complete regression of virus-induced transformation in cultures of seropositive donor leukocytes.

Authors: D J Moss; A B Rickinson; J H Pope
Journal: Int J Cancer Date: 1978-12 Impact factor: 7.396

2. Epstein Barr virus nuclear antigen positive lymphoma after cyclosporin A treatment in patient with renal allograft.

Authors: D H Crawford; J A Thomas; G Janossy; P Sweny; O N Fernando; J F Moorhead; J H Thompson
Journal: Lancet Date: 1980-06-21 Impact factor: 79.321

3. HLA antigen-related restriction of T lymphocyte cytotoxicity to Epstein-Barr virus.

Authors: I S Misko; D J Moss; J H Pope
Journal: Proc Natl Acad Sci U S A Date: 1980-07 Impact factor: 11.205

4. In vitro induction of cytotoxic T lymphocytes specific for Epstein-Barr virus-transformed cells: kinetics of autologous restimulation.

Authors: K Sugamura; Y Hinuma
Journal: J Immunol Date: 1980-03 Impact factor: 5.422

5. Differentiation-dependent sensitivity of human B-cell-derived lines to major histocompatibility complex-restricted T-cell cytotoxicity.

Authors: S Torsteinsdottir; M G Masucci; B Ehlin-Henriksson; C Brautbar; H Ben Bassat; G Klein; E Klein
Journal: Proc Natl Acad Sci U S A Date: 1986-08 Impact factor: 11.205

6. Establishment of lines from normal human blood leukocytes by co-cultivation with a leukocyte line derived from a leukemic child.

Authors: G Miller; J F Enders; H Lisco; H I Kohn
Journal: Proc Soc Exp Biol Med Date: 1969-10

7. Herpes-type virus and chromosome marker in normal leukocytes after growth with irradiated Burkitt cells.

Authors: W Henle; V Diehl; G Kohn; H Zur Hausen; G Henle
Journal: Science Date: 1967-09-01 Impact factor: 47.728

8. X-linked recessive progressive combined variable immunodeficiency (Duncan's disease).

Authors: D T Purtilo; C K Cassel; J P Yang; R Harper
Journal: Lancet Date: 1975-04-26 Impact factor: 79.321

9. Specificity of cytotoxicity T cells directed to influenza virus hemagglutinin.

Authors: T J Braciale
Journal: J Exp Med Date: 1979-04-01 Impact factor: 14.307

10. Suppression of in vitro Epstein-Barr virus infection. A new role for adult human T lymphocytes.

Authors: D A Thorley-Lawson; L Chess; J L Strominger
Journal: J Exp Med Date: 1977-08-01 Impact factor: 14.307

19 in total

Review 1. Hodgkin's disease and the Epstein-Barr virus.

Authors: K J Flavell; P G Murray
Journal: Mol Pathol Date: 2000-10

Review 2. Immune regulation of Epstein-Barr virus (EBV): EBV nuclear antigen as a target for EBV-specific T cell lysis.

Authors: D J Moss; I S Misko; T B Sculley; A Apolloni; R Khanna; S R Burrows
Journal: Springer Semin Immunopathol Date: 1991

3. Limiting-dilution analysis of the HLA restriction of anti-Epstein-Barr virus-specific cytolytic T lymphocytes.

Authors: I Bourgault; A Gomez; E Gomard; J P Levy
Journal: Clin Exp Immunol Date: 1991-06 Impact factor: 4.330

4. Stable transfection of Epstein-Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing the EBV P3HR1 genome induces expression of B-cell activation molecules CD21 and CD23.

Authors: M Cordier; A Calender; M Billaud; U Zimber; G Rousselet; O Pavlish; J Banchereau; T Tursz; G Bornkamm; G M Lenoir
Journal: J Virol Date: 1990-03 Impact factor: 5.103

5. The detection of Epstein-Barr virus in hairy cell leukemia cells by in situ hybridization.

Authors: B C Wolf; A W Martin; R S Neiman; A J Janckila; L T Yam; A Caracansi; B A Leav; R Winpenny; D S Schultz; H J Wolfe
Journal: Am J Pathol Date: 1990-03 Impact factor: 4.307

6. Identification and characterization of a human cytomegalovirus gene coding for a membrane protein that is conserved among human herpesviruses.

Authors: R Lehner; H Meyer; M Mach
Journal: J Virol Date: 1989-09 Impact factor: 5.103

Review 7. Human herpesviruses: a consideration of the latent state.

Authors: J G Stevens
Journal: Microbiol Rev Date: 1989-09

8. Susceptibility to rheumatoid arthritis maps to a T-cell epitope shared by the HLA-Dw4 DR beta-1 chain and the Epstein-Barr virus glycoprotein gp110.

Authors: J Roudier; J Petersen; G H Rhodes; J Luka; D A Carson
Journal: Proc Natl Acad Sci U S A Date: 1989-07 Impact factor: 11.205

9. Epstein-Barr virus (EBV) antigens processed and presented by B cells, B blasts, and macrophages trigger T-cell-mediated inhibition of EBV-induced B-cell transformation.

Authors: M T Bejarano; M G Masucci; A Morgan; B Morein; G Klein; E Klein
Journal: J Virol Date: 1990-03 Impact factor: 5.103

10. Herpes simplex virus type 1-specific cytotoxic T lymphocytes recognize virus nonstructural proteins.

Authors: S Martin; R J Courtney; G Fowler; B T Rouse
Journal: J Virol Date: 1988-07 Impact factor: 5.103